Subscribe to Daily Review - your favourite M&A deals update.

Submit Deal

GALDERMA

HQ - Lausanna

Summary

Galderma is a Swiss pharmaceutical company specializing in dermatological treatments and skin care products.

Deals Overview

Total Deals4

Valued Deals3

Total Value£ 1.53 B

Avg. Deal Size£ 511 M

Market Context

Senior Management

Flemming Orsnkov
CEO
Flemming Ornskov
CEO
Thomas Dittrich
CFO

Sort

05 Aug 2024|Switzerland|Pharmaceuticals

Target: GALDERMA

Bidder: L'OREAL SA

12 Service Providers

3 Target | 4 Bidder | 5 Vendor

37 Dealmakers

6 Target | 15 Bidder | 16 Vendor

£ 1.44 B

Value

22 Feb 2022|United Kingdom|Cosmetics

Target: ALCHEMEE

Bidder: TARO PHARMACEUTICAL

6 Service Providers

1 Target | 3 Bidder | 2 Vendor

38 Dealmakers

2 Target | 13 Bidder | 23 Vendor

£ 74 M

Value

29 Nov 2021|United States|Cosmetics

Target: ALASTIN SKINCARE

Bidder: GALDERMA

5 Service Providers

3 Target | 2 Bidder

41 Dealmakers

23 Target | 18 Bidder

n/a

Value

05 May 2020|Germany|Cosmetics

Target: BUBCHEN

Bidder: DALLMANN'S PHARMA

7 Service Providers

4 Bidder | 3 Vendor

2 Dealmakers

2 Vendor

£ 15 M

Value

Explore deals beyond your search with a free MergerLinks account.

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy